ABX Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbH, Heinrich-Glaeser-Strasse 10-14, D-01454 Radeberg, Germany.
Molecules. 2012 Sep 28;17(10):11554-69. doi: 10.3390/molecules171011554.
The semisynthetic oripavine derivative phenethyl orvinol (PEO), a full agonist at opioid receptors (OR), is an attractive structural motif for developing ¹⁸F-labeled PET tracers with a high degree of sensitivity for competition between endogenous and exogenous OR-ligands. The target cold reference compound 6-O-(2-fluoroethyl)-6-O-desmethylphenylethyl orvinol (FE-PEO) was obtained via two separate reaction routes. A three-step synthesis was developed for the preparation of a tosyloxyethyl precursor (TE-TDPEO), the key precursor for a direct, nucleophilic radiofluorination to yield [¹⁸F]FE-PEO. The developed radiosynthesis provides the target compound in relevantly high yield and purity, and is adaptable to routine production.
半合成或派定衍生物苯乙基奥文醇(PEO)是阿片受体(OR)的完全激动剂,是开发具有高灵敏度的用于内源性和外源性 OR 配体之间竞争的¹⁸F 标记正电子发射断层扫描(PET)示踪剂的有吸引力的结构基序。目标冷参考化合物 6-O-(2-氟乙基)-6-O-去甲基苯乙基奥文醇(FE-PEO)通过两条单独的反应路线获得。开发了三步合成法来制备对甲苯磺酰氧基乙基前体(TE-TDPEO),这是直接亲核放射性氟化以生成 [¹⁸F]FE-PEO 的关键前体。所开发的放射合成以相当高的产率和纯度提供目标化合物,并且适应于常规生产。